Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Staccato Loxapine for Inhalation in Subjects on Chronic, Stable Antipsychotic Regimens
Phase of Trial: Phase I
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Loxapine (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Alexza Pharmaceuticals
- 27 May 2010 Results of this and another phase I loxapine safety trial (700043576) will be presented at the 163rd Annual Scientific Sessions of the American Psychiatric Association, according to an Alexza Pharmaceuticals media release.
- 26 May 2010 Tolerability results, with respect to the incidence of cardiovascular adverse events, presented at the 163rd Annual Meeting of the American Psychiatric Association.
- 08 Nov 2007 New trial record.